Position in BCRX
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$400,000
+$19,200 QoQ
Shares Held
40,000
0.0% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#174
of 318 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Erste Asset Management GmbH holds $19,400,632 across 6 Drug Manufacturers - Specialty & Generic names. BCRX ranks #3 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
28,831 | $15,621,500 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
19,700 | $3,320,238 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
40,000 | $400,000 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
3,674 | $58,894 | |
| 5 | RDY |
Dr Reddys Laboratories Ltd
|
0 | $0 | |
| 6 | ZTS |
Zoetis Inc.
|
0 | $0 |
All Filings in BCRX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $400,000 | 40,000 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $380,800 | 40,000 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $312,000 | 40,000 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $303,600 | 40,000 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $358,400 | 40,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $300,000 | 40,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $300,800 | 40,000 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $304,000 | 40,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $247,200 | 40,000 | Shares | Sole | 2024-11-26 | |
| 2024-03-31 | $203,200 | 40,000 | Shares | Sole | 2024-11-26 | |
| 2023-12-31 | $239,600 | 40,000 | Shares | Sole | 2024-11-26 | |
| 2023-09-30 | $283,200 | 40,000 | Shares | Sole | 2024-11-26 | |
| 2023-06-30 | $281,600 | 40,000 | Shares | Sole | 2024-11-26 | |
| 2023-03-31 | $333,600 | 40,000 | Shares | Sole | 2024-11-26 | |
| 2022-12-31 | $459,200 | 40,000 | Shares | Sole | 2024-11-26 | |
| 2022-09-30 | $504,000 | 40,000 | Shares | Sole | 2024-11-26 | |
| 2022-06-30 | $423,200 | 40,000 | Shares | Sole | 2024-11-26 | |
| 2022-03-31 | $650,400 | 40,000 | Shares | Sole | 2024-11-25 | |
| No filing history on record for this holder in this stock. | ||||||